Mark Hahn

Mark Hahn

63 year
Health Technology
Communications
Technology Services

Profile

Mr. Mark W.
Hahn
, CPA, is a Chairman at Slate Medicines, Inc. /New/ and an Independent Director at ALSP Orchid Acquisition Corp.
I.
He is on the Board of Directors at ALSP Orchid Acquisition Corp.
I and Opterion Health AG.
Mr. Hahn was previously employed as an Independent Director by Soleno Therapeutics, Inc., a Secretary & Treasurer by Verona Pharma Ltd., a Chief Financial Officer by Dova Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Cempra Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Cempra, Inc., a Chief Financial Officer by Athenix Corp., a Chief Financial Officer & VP-Administration by Gigabeam Corp., a Chief Financial Officer by Equitel, Inc., a Chief Financial Officer by BuildLinks, Inc., a Chief Financial Officer by C3, Inc., a Principal by Ernst & Young LLP, and a Chief Financial Officer by Performaworks, Inc. He received his undergraduate degree from the University of Wisconsin-Milwaukee.

Mark Hahn active positions

CompaniesPositionStart
ALSP ORCHID ACQUISITION CORPORATION I Director/Board Member 01/11/2021
Director/Board Member -

Former positions of Mark Hahn

CompaniesPositionEnd
SOLENO THERAPEUTICS, INC. Director/Board Member 15/05/2026
DOVA PHARMACEUTICALS, INC. Director of Finance/CFO 12/11/2019
Director of Finance/CFO 30/11/2017
Director of Finance/CFO 01/11/2017
Director of Finance/CFO 01/01/2009
See the detail of Mark Hahn's experience

Education of Mark Hahn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance